Emerging from the UK, retatrutide, a novel molecule, is sparking considerable interest within the healthcare community regarding its promise for body management . This dual GIP and GLP-1 receptor agonist seems to provide a significant benefit over current therapies, showing promising results in early clinical trials . Researchers suggest its distin